Comparative Bioavailability of Sublingual TNX-102, Oral and Intravenous Cyclobenzaprine in Healthy Adults

Condition:   Healthy AdultsInterventions:   Drug: SL TNX-102 2.4 mg at pH 3.5;   Drug: SL TNX-102 2.4 mg at pH 7.1;   Drug: Cyclobenzaprine Tablet;   Drug: Cyclobenzaprine IVSponsor:   Tonix Pharmaceuticals, Inc.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials